PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1273559
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1273559
According to Stratistics MRC, the Global Neurovascular Catheters Market is accounted for $3.3 billion in 2022 and is expected to reach $5.8 billion by 2028 growing at a CAGR of 9.8% during the forecast period. Neurovascular catheters are also useful for delivering neurovascular devices to neurovascular organs, such as the brain. The use of neurovascular catheters in numerous cranial surgeries is a result. The use of neurovascular catheters has gradually increased as a result of a considerable increase in neurological procedures. Additionally, there have been a number of advancements in the treatment of ischemic stroke, including flow-rerouting stents and stent retrievers that are assisting in the catheter industry.
According to the estimations of Centers for Disease Control and Prevention, around 795,000 people in the U.S. suffer from a stroke each year.
Along with other neurovascular devices, neurovascular catheters are utilised in the treatment of strokes. Consequently, neurovascular catheters are applied in various cranial procedures. There has been a significant rise in the number of neurological procedures gradually increasing the consumption of neurovascular catheters. Also, introduction of advanced catheters with ergonomic designs and improved clinical efficiency is fueling the market growth.
Despite an increase in the frequency of strokes and haemorrhages as well as a sizable patient population suffering from neurovascular illnesses, there are some limitations that are preventing the widespread use of neurovascular catheters. This is brought on by the procedures' high cost and the unfavourable reimbursement policies. As a result, there are fewer patients receiving therapy and fewer catheters are being used in these nations.
The transition from open surgery to minimally invasive surgery has been crucial in the development of sophisticated neurovascular catheters for many uses. The demand for these catheters is rising in both developed and developing nations due to the rising incidence of stroke and the prevalence of neurological illnesses as well as the preference of healthcare providers for less invasive surgeries.
The procedural concerns connected to the use of these catheters provide certain difficulties for the market. One of the main factors restricting the demand for neurovascular catheters in the market is the risk of catheter blockage, coating removal from the catheter, and its biocompatibility with neurovascular organs. Furthermore, strict rules are also preventing the market from expanding.
Medical supplies are increasingly in demand as a result of the afflicted population. Among the most common medical devices used in first-line clinical care are respiratory support devices such atomizers, life support machines, oxygen generators, and monitors. Additionally, COVID-19 has caused a significant increase in demand for medical goods such masks, gloves, and protective eyewear. The demand for medical goods is continuously increasing from both healthcare professionals and the general public as a result of an increase in instances around the world.
The microcatheters segment is estimated to have a lucrative growth, due to the rising prevalence of acute ischemic stroke. For neurovascular treatments, they are tiny, hollow tubes that are placed into blood vessels. These advanced catheters are made with a variety of features, including a hydrophilic coating, softness, trackability, and stability. The segment's expansion will be fueled in the near future by an increase in the number of growth methods used by major market participants, such as product launches.
The ambulatory surgical centers segment is anticipated to witness the fastest CAGR growth during the forecast period, due to shorter procedure time and advancements in minimally invasive surgical techniques. In comparison to hospitals, they provide patients with a number of benefits, including as faster operation times and same-day discharge. Patients can save a lot of money by using them because they can be less expensive than hospitals. These factors have contributed to its rapid growth.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as rising target disease burden, technological advancements, increasing prevalence of neurological disorders. The increasing incidence of neurovascular illnesses in this region, such as ischemia, brain aneurysms, and arteriovenous malformations, is one reason contributing to this rise. Additionally, the region's growth is being aided by the presence of important players in the area and growing healthcare costs.
Europe is projected to have the highest CAGR over the forecast period, owing to the rising awareness about the neurovascular disorders, the increasing focus on minimally invasive surgeries, and high adoption of advanced catheters. The expansion of the regional market is also being considerably aided by greater government activities as well as increasing R&D spending by businesses.
Some of the key players profiled in the Neurovascular Catheters Market include: Integra Holdings Corporation, Stryker, Concentric Medical, Inc., Medtronic, Johnson and Johnson company, Zeus Industrial Products, Acandis GmbH, Terumo Corporation, Penumbra, Inc., Biomerics, Creganna Medical, Microvention Inc. and DePuy Synthes.
In September 2021, Medtronic PLC received CE approval for Rist 079 Radial Access Guide and Rist Radial Access Selective Catheter. It aims to cater the needs of accessing neuro vasculature through the radial artery.
In June 2021, Penumbra received US FDA Clearance for its RED 62 catheters, designed with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots.
All the customers of this report will be entitled to receive one of the following free customization options: